Kusajili – Clinical trials directory

Result of your search per sponsor: Susan Creary, MD

Woman and Man Max 99 years
Susan Creary, MD Update Il y a 4 ans

ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease HU is an FDA approved medication for the treatment of SCD. Many studies have shown that HU can reduce SCD related symptoms, but only 50% of patients take it as often as they should. This l...

Country None
organs None
Specialty None

Opened trial

More information